Assessment of fibroblast growth factor 21 in children with type 1 diabetes 
mellitus in relation to microvascular complications

Nermien Tantawy; Eman Sherif; Randa M. Matter; Nouran Salah; Nour Eldin Abozeid; Heba Atif

doi:10.5114/pedm.2022.121372

Streszczenie

2/2023 vol. 29

Artykuł oryginalny

Ocena czynnika wzrostu fibroblastów 21 u dzieci z cukrzycą typu 1 w odniesieniu do powikłań mikronaczyniowych

Nermien M. Tantawy ¹

,

Eman M. Sherif ¹

,

Randa M. Matter ¹

,

Nouran Y. Salah ¹

,

Nour Eldin H. Abozeid ²

,

Heba M. Atif ³

Paediatrics Department, Paediatric and Adolescent Diabetes Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Opthalmology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Pediatr Endocrinol Diabetes Metab 2023; 29 (2): 67-74

DOI: https://doi.org/10.5114/pedm.2022.121372

Data publikacji online: 2023/05/26

Pełna treść artykułu

AMA

Tantawy NM, Sherif EM, Matter R, Salah NY, Abozeid NH, Atif HM. Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications. Pediatric Endocrinology Diabetes and Metabolism. 2023;29(2):64-74. doi:10.5114/pedm.2022.121372.

APA

Tantawy, N. M., Sherif, E. M., Matter, R., Salah, N. Y., Abozeid, N. H., & Atif, H. M. (2023). Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications. Pediatric Endocrinology Diabetes and Metabolism, 29(2), 64-74. https://doi.org/10.5114/pedm.2022.121372

Chicago

Tantawy, Nermien M, Eman M Sherif, Randa M. Matter, Nouran Y Salah, Nour Eldin H Abozeid, and Heba M Atif. 2023. "Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications". Pediatric Endocrinology Diabetes and Metabolism 29 (2): 64-74. doi:10.5114/pedm.2022.121372.

Harvard

Tantawy, N., Sherif, E., Matter, R., Salah, N., Abozeid, N., and Atif, H. (2023). Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications. Pediatric Endocrinology Diabetes and Metabolism, 29(2), pp.64-74. https://doi.org/10.5114/pedm.2022.121372

MLA

Tantawy, Nermien et al. "Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications." Pediatric Endocrinology Diabetes and Metabolism, vol. 29, no. 2, 2023, pp. 64-74. doi:10.5114/pedm.2022.121372.

Vancouver

Tantawy N, Sherif E, Matter R, Salah N, Abozeid N, Atif H. Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications. Pediatric Endocrinology Diabetes and Metabolism. 2023;29(2):64-74. doi:10.5114/pedm.2022.121372.

Udostępnij

Zintergrowane z

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications